Pepdox
Studies
Peptides
Calculator
A new indication for semaglutide (Wegovy). | Pepdox
Home
/
Search
/
PMID 38691645
A new indication for semaglutide (Wegovy).
The Medical letter on drugs and therapeutics
2024
PMID: 38691645
View on PubMed
DOI: 10.58347/tml.2024.1701b
Semaglutide
Tirzepatide
Keywords
Byetta
Mounjaro
Trulicity
Victoza
Wegovy
Zepound
adverse effects
cardiovascular disease
dosage
dulaglutide
efficacy
exenatide
liraglutide
safety
semaglutide
tirzepatide
weight loss